22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522937132/en/Enanta-Pharmaceuticals-Announces-Data-from-its-Phase-2-Study-of-Zelicapavir-in-Children-with-Respiratory-Syncytial-Virus-to-be-Presented-at-the-43rd-Annual-ESPID-Meeting